{
    "title": "Relief Therapeutics stock plunges after FDA rejects COVID-19 emergency approval",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-9098517/Relief-Therapeutics-stock-plunges-FDA-rejects-COVID-19-emergency-approval.html",
    "date": "2020-12-30",
    "keywords": [
        "drug",
        "covid19",
        "company",
        "relief",
        "emergency",
        "aviptdadil",
        "trial",
        "stock",
        "wednesday",
        "food",
        "administration",
        "bid",
        "approval",
        "use",
        "authorisation",
        "september",
        "jonathan",
        "javitt",
        "officer",
        "neurorx",
        "inc",
        "gmt",
        "year",
        "enrollment",
        "january",
        "quarter",
        "halfcenturyold",
        "aviptadil",
        "variety",
        "dysfunction",
        "fibrosis",
        "part",
        "portfolio",
        "coronavirus",
        "zyesami",
        "formulation",
        "reporting",
        "john",
        "miller",
        "editing",
        "jason"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}